ArticleFrontiers in immunology2020

Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.

Maria Grazia Narducci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.